FTLD-U is the most common variant of FTLD. FTLD, a heterogeneous syndrome characterized by progressive dementia, is caused by degeneration of the frontal and anterior temporal lobes, and is a leading cause of dementia in patients presenting before the age of 65 years (5). The pathogenesis of FTLD remains unknown. ALS is the most common motor neuron disease, characterized by progressive loss of motor neurons (6, 7). The pathogenesis of ALS remains undetermined although various hypotheses have been proposed: e.g. misfolded protein aggregates, mitochondrial dysfunction, glutamate toxicity, oxidative stress, disturbance of intracellular trafficking, and ER stress (8). About 10% of ALS cases occur in a genetically inherited manner.Post-translational modifications of TDP-43 including truncation, hyperphosphorylation, and ubiquitination are assumed to be linked to abnormal aggregation (1, 2). In particular, C-terminal fragments (CTFs) of TDP-43 are prone to form cytoplasmic aggregates (9 -11). Although it is apparent that cytoplasmic aggregates of TDP-43 are closely related to the pathogenesis of FTLD-U and ALS, it remains unknown how CTFs are generated and whether the aggregate formation of TDP-43 is a cause or a result of neuronal toxicity.Caspase activation has been observed in motor neurons of ALS (12-15) and neurons in FTLD patients (16). One possible mechanism underlying the generation of CTFs is the cleavage of TDP-43 by activated caspases. In reality, multiple studies have shown that TDP-43 is cleaved in a caspase-dependent manner and the resulting CTFs of TDP-43 are constituents in the inclusion bodies (17)(18)(19).Some clinical studies have suggested that the levels of TDP-43 are up-regulated in motor neurons of sporadic ALS patients, based on the finding that the levels of TDP-43 are up-regulated in cerebrospinal fluids (20)